One of the only known histone 3 lysine 79 (H3K79) methyltransferases, is the histone methylase disruptor silencing 1 like (DOT1L) which has critical role in the development of breast cancer and is a potential therapeutic target for invasive breast cancer (124, 125). The gene discussed is DOT1L; the disease is breast carcinoma.